Navigation Links
Adeona Reports Second Quarter 2011 Financial Results
Date:8/15/2011

ANN ARBOR, Mich., Aug. 15, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, today reported its second quarter 2011 financial results for the period ended June 30, 2011, as well as updates since the beginning of the second quarter.

Updates since the beginning of the second quarter include:

Drug Development Programs

Multiple Sclerosis (MS)

  • As of August 1, 2011, 140 of 150 patients have been enrolled in the clinical trial evaluating Trimesta in women suffering from relapsing-remitting MS. The randomized, double-blind, placebo-controlled clinical trial is currently underway at 15 centers in the United States and should complete enrollment before the end of 2011.

  • Our ongoing Phase II clinical trial of Trimesta (estriol) for relapsing-remitting MS in women has received over $8 million in total grant awards and should support the clinical trial to its completion.

  • We are planning to sponsor a separate randomized, double-blind, placebo-controlled clinical trial to evaluate Trimesta's effect on cognition in female MS patients.

Fibromyalgia

  • In May 2010, we announced a $17.5 million corporate partnership with Meda AB for the development and commercialization of flupirtine for fibromyalgia. Meda assumed all future development costs and estimates the U.S. market for fibromyalgia to be near $1 billion at the time of potential launch of flupirtine. We are eligible to receive up to $15 million of additional milestone payments and royalties on sales.  

  • In its 2010 Annual Report that was publi
    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Adeona to Host Second Quarter 2011 Investor Conference Call
2. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
3. Adeona Reports 1st Quarter 2011 Financial Results
4. Adeona to Host First Quarter 2011 Investor Conference Call
5. Adeona Executes Manufacturing and Supply Agreement with TG United for reaZin™
6. Adeonas Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper
7. Adeona to Host Conference Call
8. Adeona to Raise $3.5 Million in Registered Direct Offering
9. Adeona Reports 2010 Year End Financial Results
10. Adeona to Host 2010 Year End Investor Conference Call
11. Adeonas Multiple Sclerosis Trial Receives $409,426 Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Akron Children,s Hospital has been designated a Diagnostic ... of Radiology (ACR), making it the first hospital in ... hospital in the United States ... from the ACR as a DICOE provides validation that ... with national benchmarks," says Dr. Michael Rubin , ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... DIEGO , March 2, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and t:flex™ ... previously announced public offering of common stock have exercised ... its common stock at a price to the public ... from the offering is expected to be $64.8 million, ...
Breaking Medicine Technology:Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... After a rigorous evaluation process that ... and long-term strategy, Blood Centers of America (BCA) has ... member centers’ testing needs. , BCA, which comprises more ... 30 percent of the U.S. blood supply, made the ... committed to drive cost savings to members,” said Bill ...
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
(Date:3/2/2015)... 2015 Over the last five years ... vendors seeking to expand their geographic presence and achieve ... to reach $6.2 billion by 2019 at CAGR of ... the U.S. and Canada and a major part of ... regions such as Asia-Pacific including China and India, Latin ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... researchers say , MONDAY, Oct. 19 (HealthDay News) -- ... nausea and vomiting as much if they take dextrose, ... the most common post-operative complications, [vomiting and nausea] remains ... following surgery," said Dr. Susan Dabu-Bondoc of Yale School ...
... say , MONDAY, Oct. 19 (HealthDay News) -- The ... (IBD) increases the risk of cancers related to viral ... Crohn,s disease and ulcerative colitis. Thiopurine drugs are used ... remission in IBD patients. , For this study, French ...
... The Board of Directors of the ... assistance organizations, is pleased to announce the appointment of ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090930/NY84016LOGO ) ... Directors of the HealthWell Foundation commented, "Mary is an ...
... N.J. Oct. 19 America,s Toughest Trainer and Health ... is designed specifically for on-the-go fitness! Majesco Entertainment Company ... games for the mass market, and Interactive Game Group, ... for Nintendo DS(TM) will be available at retailers ...
... Funding has brought together under a single domain ( ... tools organizations need for a complete end-to-end OPEB liability ... consultants and other service providers, Roundstone Healthcare Funding and ... liability estimation, dedicated Trust formation, strategic asset management services ...
... IPRO has been awarded special federal funding to ... As the Medicare Quality Improvement Organization (QIO) for the ... performance improvement in a variety of settings. QIOs operate ... with the federal Centers for Medicare & Medicaid Services ...
Cached Medicine News:Health News:Easy Way to Prevent Post-Op Nausea? 2Health News:Drugs for Inflammatory Bowel Might Increase Cancer Risk 2Health News:HealthWell Foundation(R) Appoints New Executive Director 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 3Health News:IPRO Wins Federal Contract to Support Hospice Oversight 2
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: